Showing 141 - 160 results of 506 for search '"combination therapy"', query time: 0.06s Refine Results
  1. 141

    Attention Deficit Disorder and Allergic Rhinitis: Are They Related? by Isaac Melamed, Melinda Heffron

    Published 2016-01-01
    “…For allergy endpoints, combination therapy produced results superior to individual therapy. …”
    Get full text
    Article
  2. 142

    Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma by Ryoko Igarashi, Tetsuya Togano, Yuta Sakaue, Takaiko Yoshino, Jun Ueda, Takeo Fukuchi

    Published 2014-01-01
    “…Switching to fixed combination therapy from PG monotherapy, the mean IOP was 13.1±1.79 mmHg (P<0.001)  (-24.71% reduction from baseline) at 6 months. …”
    Get full text
    Article
  3. 143

    Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma by Yinfang Gu, Xiaofang Zou, Junlin Zhu, Guowu Wu

    Published 2025-02-01
    “…However, the median PFS was significantly longer in the combination therapy group compared to the chemotherapy group (4.7 months vs. 3.4 months, P = 0.048). …”
    Get full text
    Article
  4. 144

    Regeneration of Pancreatic β-Islet Cells in a Type-II Diabetic by Edwin C. Jones, J. Craig Rylands, Cortney L. Jardet

    Published 2018-01-01
    “…Treatment periods consisted of metformin therapy alone for 4 years followed by a metformin/glyburide combination therapy for 6 years, and eventually an insulin/metformin combination therapy for 4 years. …”
    Get full text
    Article
  5. 145

    Intravitreal Conbercept with Grid/Focal Photocoagulation for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis by Xiaoyan Sun, Wei Wei

    Published 2022-01-01
    “…The combination therapy group significantly increased the level of effectiveness and best-corrected visual acuity (BCVA) compared with the control group. …”
    Get full text
    Article
  6. 146

    Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors by Maansi Joshi, Stephen M. Ansell

    Published 2020-01-01
    “…Anti-PD-1 and anti-CTLA-4 antibodies have been tested as both single agents and combination therapy. Although success rates with anti-PD-1 antibodies are high in patients with Hodgkin lymphoma, the results are yet to be replicated in those with non-Hodgkin lymphomas. …”
    Get full text
    Article
  7. 147
  8. 148

    Clinical Profile and Prescription Patterns in Culture-proven Enteric Fever in Children by Divya Priyadharshini, Mobill Clinton, Nandini Sethuraman, Mathrubootham Sridhar, Vidya Krishna

    Published 2024-03-01
    “…Fever typically resolved in 4–5 days, with paratyphoid fever resolving earlier. Combination therapy was used in over two-thirds of cases. …”
    Get full text
    Article
  9. 149

    Iron Chelators in Treatment of Iron Overload by Sarina Entezari, Seyedeh Mona Haghi, Narges Norouzkhani, Barsa Sahebnazar, Fatemeh Vosoughian, Diba Akbarzadeh, Muhammad Islampanah, Navid Naghsh, Mohammad Abbasalizadeh, Niloofar Deravi

    Published 2022-01-01
    “…This study aimed to introduce each of these iron chelators, combination therapy, usage doses, specific clinical applications, and their advantages, toxicity, and side effects.…”
    Get full text
    Article
  10. 150

    Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations by Nicholas New, Janaki Mohandas, George T. John, Sharad Ratanjee, Helen Healy, Leo Francis, Dwarakanathan Ranganathan

    Published 2011-01-01
    “…This combination therapy may be changing the historically poor prognosis of calcific uremic arteriolopathy reported in the literature. …”
    Get full text
    Article
  11. 151

    The Impact of Levothyroxine and Testosterone Administration on Bladder Contractility in the Rat Model of Propylthiouracil-Induced Hypothyroidism by Didem Yılmaz Oral, Berna Güven Ciloğlu, Serap Gür

    Published 2024-07-01
    “…In males with hypothyroidism and urogenital system dysfunction, combination therapy with thyroid hormones and T has a major impact on repairing detrusor smooth muscle contractility and bladder histomorphology.…”
    Get full text
    Article
  12. 152

    Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation by Austin Clark, Brendan Tate, Bretton Urban, Ryan Schroeder, Sonja Gennuso, Shahab Ahmadzadeh, David McGregor, Brook Girma, Sahar Shekoohi, Alan D. Kaye

    Published 2023-07-01
    “…Additional research is needed to determine the drug's full clinical potential, particularly in the areas of adolescent depression and combination therapy with varenicline or dextromethorphan. …”
    Get full text
    Article
  13. 153

    First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours by Michael Smith, Aung Naing, Todd Bauer, Kyriakos P Papadopoulos, Osama Rahma, Elena Garralda, Glenn J Hanna, Michael J Pishvaian, Xuejun Chen, Sven Gogov, Omar Saavedra, Howard Kallender, LuLu Cheng, Emil Kuriakose

    Published 2024-07-01
    “…The most common INCB001158-related AEs were fatigue (n=10/107 (9.3%)) and nausea (n=10/107 (9.3%)) with monotherapy and diarrhoea (n=24/147 (16.3%)) and fatigue (n=22/147 (15.0%)) with combination therapy. The highest response rate was seen in the anti–PD-1/PD-L1–naive combination therapy group with head/neck squamous cell carcinoma (overall response rate, 19.2%; 4/26 partial responses, 1/26 complete response). …”
    Get full text
    Article
  14. 154

    Combination Fractional Carbon Dioxide Laser Treatment and Bone Marrow Mesenchymal Stem Cell Therapy Enhances the Treatment of Skin Photoaging in a Murine Model System by Li L, He Z, Yu C, Zhang C, Yu Y, Li Y, Xu X

    Published 2025-01-01
    “…The improvement of effect may be due to the decrease of MMP-3 and MMP-9 expression in combination therapy.Keywords: bone marrow mesenchymal stem cell, fractional carbon dioxide laser, photoaging, matrix metalloproteinase, mouse model…”
    Get full text
    Article
  15. 155

    The effect of repetitive transcranial magnetic stimulation on sleep quality in patients with more than mild depressive mood: a systematic review and meta-analysis by Yu’ang Liu, Silang Huang, Xinxin Zhang, Huangying Liao, Weiguo Liu, Zhi Zhang, Xianhui Qu, Ziwen Wang

    Published 2025-02-01
    “…In terms of whether combination therapy was used or not, compared with the combination therapy group (I2 = 29%, MD = −1.39, 95%CI = −2.30 to −0.48, p = 0.003), the non-combination therapy group had a better treatment effect (I2 = 0%, MD = −2.93, 95%CI = −3.36 to −2.50, p &lt; 0.00001).ConclusionrTMS significantly improves sleep quality in patients with more than mild depression. …”
    Get full text
    Article
  16. 156

    National Trends of Antiparkinsonism Treatment in Taiwan: 2004–2011 by Weng-Ming Liu, Ruey-Meei Wu, Chia-Hsuin Chang, Jou-Wei Lin, Ying-Chun Liu, Chin-Hsien Lin

    Published 2016-01-01
    “…Levodopa monotherapy or combination therapy was the mainstay. Levodopa monotherapy comprised 37.4% of prescriptions in 2004 and 44.2% in 2011, with an annual increase rate of 18.14%. …”
    Get full text
    Article
  17. 157
  18. 158

    IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis by Robin Rauniyar, Aman Mishra, Sanjeev Kharel, Subarna Giri, Rohit Rauniyar, Shikha Yadav, Gajendra Chaudhary

    Published 2022-01-01
    “…This study supports the use of IVIG with glucocorticoids compared to IVIG alone, as the combination therapy significantly lowered the risk of treatment failure and the need for adjunctive immunomodulatory therapy.…”
    Get full text
    Article
  19. 159

    Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021 by Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim

    Published 2025-02-01
    “…However, the proportion of individuals receiving monotherapy or dual combination therapy decreased by 9.2 percentage points, whereas the proportion prescribed triple or more combination therapy increased. …”
    Get full text
    Article
  20. 160

    Montelukast Use and Patterns of Ambulatory Care among Asian versus Non-Asian Adult Patients with Asthma and/or Allergic Rhinitis in the United States by Joseph Vasey, Shalini Bagga, Huan Huang, Tongsheng Wang, David Thompson

    Published 2015-12-01
    “…**Results:** Overall patterns of use of montelukast were similar for Asian and non-Asian patients, but Asians were more likely to receive it as part of a combination therapy regimen. Changes in treatment regimen followed similar patterns for both groups. …”
    Get full text
    Article